Men's Health News

RSS

Astellas, Medivation announce acceptance of XTANDI sNDA for review by FDA

Astellas Pharma Inc. and Medivation, Inc. today announced that the U.S. Food and Drug Administration has accepted for review a supplemental New Drug Application (sNDA) that they have submitted for XTANDI (enzalutamide) capsules in metastatic castration-resistant prostate cancer (mCRPC), which includes findings from the Phase 2 TERRAIN and STRIVE studies, to update the relevant clinical sections within the current indication.

22 Feb 2016

FSU researchers explore new method to decipher genetic data for new prostate cancer treatments

Florida State University researchers are working on new approaches to deciphering genetic data that may lead to new, more targeted prostate cancer treatments.

22 Feb 2016

Over a third of US population not getting enough sleep

A large study of US adults, conducted collaboratively by state health departments and the CDC, has shown that over a third of the population are regularly not getting enough sleep. This is the first study to obtain self-reported estimates of sleep duration for all 50 US states and the District of Columbia.

19 Feb 2016

Active surveillance recommended for low-risk prostate cancer

For most men with low-risk prostate cancer, the recommended strategy is active surveillance with regular testing to check for cancer growth rather than immediate treatment, according to guidelines from the American Society of Clinical Oncology.

18 Feb 2016

Testosterone treatment for older men improves sexual function, walking ability and mood

As men age, their testosterone levels decrease, but prior studies of the effects of administering testosterone to older men have been inconclusive. Now, research shows that testosterone treatment for men over 65 improves sexual function, walking ability and mood, according to a study published in the New England Journal of Medicine by team researchers from the Perelman School of Medicine at the University of Pennsylvania, and twelve other medical centers in the United States, in partnership with the National Institute on Aging.

18 Feb 2016

Young men’s attitude toward risky sex, pregnancy can predict fatherhood patterns

A new Northwestern Medicine study has found an adolescent male's attitude toward risky sex, pregnancy and birth control can predict whether or not he will end up living with his future offspring.

17 Feb 2016

Study shows male cancer survivors less likely to have children

A study of all Norwegian men born between 1965 and 1985 shows that male cancer survivors are less likely to have children than those without a cancer diagnosis.

17 Feb 2016

Sonablate HIFU now available in southern California for treatment of prostate cancer patients

HIFU Prostate Services, LLC, a leading provider of minimally-invasive prostate cancer treatment using high intensity focused ultrasound, announces that Sonablate HIFU is now available in southern California through a partnership established with Western States HIFU and Pacific Coast Urology and one of the most experienced HIFU physicians in the world, Robert Pugach, MD.

16 Feb 2016

New report focusing on erectile dysfunction from female perspective published by Superdrug Online Doctor

Erectile dysfunction is a common condition that can affect men everywhere, in fact more than half of men aged 40-70 have been affected.

15 Feb 2016

Intracellular process of autophagy plays role in prostate cancer development, shows research

Research from investigators at Rutgers Cancer Institute of New Jersey and the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, shows the intracellular process of autophagy plays a role in the development of prostate cancer.

15 Feb 2016

Liverpool researchers reach major milestone towards creating diagnostic test for prostate cancer

A research team from the University of Liverpool has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.

12 Feb 2016

ASTRO's new research journal 'Advances in Radiation Oncology' closes first issue

Advances in Radiation Oncology, ASTRO's new original research journal, has closed its first issue with research including a phase II clinical trial in prostate cancer, a prospective trial in quality of life for breast cancer patients receiving radiotherapy and several clinical and medical physics reports on the use of stereotactic body radiotherapy.

12 Feb 2016

Study looks at post-treatment resources for prostate cancer patients transitioning to survivorship

The System Partner of Rutgers Cancer Institute of New Jersey, Meridian Health is joining forces with Rutgers Cancer Institute in offering access to a research study aimed at prostate cancer patients who are transitioning to survivorship.

11 Feb 2016

Vanderbilt physicians examine risk factors for cardiovascular disease in prostate cancer survivors

The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease's slow progression.

11 Feb 2016

2020 dementia challenge to be tackled by MOOC

The University of Derby’s Massive Open Online Course (MOOC) titled ‘Bridging the Dementia Divide’ is back by popular demand after the University received high levels of requests to run the course again.

From University of Derby Online Learning 9 Feb 2016

VolitionRx initiates study to assess NuQ blood tests for detection of prostate cancer

VolitionRx Limited today announced that it has initiated a study to assess the feasibility of using the Company’s NuQ blood tests to detect prostate cancer. The study is in collaboration with the Surrey Cancer Research Institute of the University of Surrey in the UK.

5 Feb 2016

Strong link found between incarceration of family members during childhood and heart attacks in men

A parent's incarceration has immediate, devastating effects on a family. Now, Virginia Tech and University of Toronto researchers say there may be a longer term risk: Men who as children experienced a family member's incarceration are approximately twice as likely to have a heart attack in later adulthood in comparison with men who were not exposed to such a childhood trauma.

5 Feb 2016

NICE recommends Xofigo (radium-223 dichloride) for prostate cancer patients after treatment with docetaxel

The National Institute for Health and Care Excellence has issued its final guidance recommending Xofigo for use on the NHS in England and Wales as an option for treating adult men, with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases, who have received previous docetaxel therapy.

4 Feb 2016

NJHF awards 30 grants for NJ researchers working on health-related research

New Jersey Health Foundation has awarded 30 grants totaling more than $1 million for researchers in New Jersey who are working on health-related research that demonstrates exciting potential.